Nisa Investment Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Nisa Investment Advisors's VKTX Position: Q2 2026 in Review
Nisa Investment Advisors reduced its Viking Therapeutics (VKTX) stake by 76% in Q2 2026, selling an estimated $464K and leaving 4,493 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.
Nisa Investment Advisors first reported a position in VKTX in Q4 2018 and has held it in 17 quarters since. The position peaked at $3.17M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Nisa Investment Advisors held 4,493 shares of Viking Therapeutics worth $175K as of Q2 2026.
- Nisa Investment Advisors sold 14,354 Viking Therapeutics shares in Q2 2026, an estimated $464K.
- Viking Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1299 holding.
- Nisa Investment Advisors first reported a position in Viking Therapeutics in Q4 2018 and has held it in 17 quarters since.
- Nisa Investment Advisors's Viking Therapeutics position peaked at $3.17M in Q3 2024.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.